Kiniksa Pharmaceuticals International Plc (KNSA)

Finanzdaten der Kiniksa Pharmaceuticals International Plc-Aktie (KNSA)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	17.39%285.97	243.60	214.27	202.13	180.86
Cost Of Revenue	17.76%27.76	23.57	20.80	20.95	20.26
	2.34%65.36	63.87	61.15	-	-
Selling, General, and Administrative	2.34%65.36	63.87	61.15	-	-
Research and Development	19.84%32.79	40.90	27.48	-	-
Depreciation and Amortization	3.81%0.49	0.47	0.47	0.47	0.38
Operating Income/Loss	99.44%54.24	27.19	29.27	19.77	24.02
Income/Loss From Continuing Operations Before Tax	89.62%59.06	31.15	32.68	23.27	27.16
Income Tax Expense/Benefit, Deferred	346.71%-6.57	2.66	4.52	3.14	4.23
Income Tax Expense/Benefit	105.01%11.71	5.71	10.09	9.07	8.72
	86.16%47.35	25.43	22.59	14.20	18.44
Attributable To Parent	86.16%47.35	25.43	22.59	14.20	18.44
Basic Average Shares	0.79%78.19	77.58	76.52	0.60	74.71
Diluted Average Shares	1.82%84.92	83.40	82.41	0.95	80.04
Basic Earnings Per Share	84.85%0.61	0.33	0.30	0.19	0.25
Diluted Earnings Per Share	86.67%0.56	0.30	0.27	0.18	0.23